HeartWare Announces New 450 Person Trial for its Ventricular Assist System

Posted on May 9, 2012

A federal advisory panel recently recommended the approval of HeartWare's ventricular assist system. The advisory committee voted 9 to 2 that the benefits outweigh the risks for the use of the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure. HeartWare recently announced a new 450-patient clinical trial for the device. The system, which is implanted inside a patient, keeps a failing heart pumping while a patient is waiting for a heart transplant to become available.

NMA News created an animation showing how the VAD works. Take a look:

More from Science Space & Robots

  • Boston Dynamics Teases New Electric Atlas Humanoid Robot


  • Researchers Observe Many New Species on Seamounts Off Chile Coast


  • CSU Researchers Forecast Extremely Active Atlantic Hurricane Season


  • Hyundai Motor and Kia Unveil DAL-e Delivery Robot


  • H5N1 Discovered at Texas Egg Facility



    • Latest Tech Products

  • Apple Mac Mini with M4 Chip

  • Apple iPad Mini A17 Pro